Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial-Reference-Cited by-同舟云学术

Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial

Published:2021-11 Issue:6 Volume:47 Page:101280
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Fernandes Vicente Hidalgo Rodrigues^ORCID,Chaves Fernando R.P.,Soares Alexandre A.S.,Breder Ikaro,Kimura-Medorima Sheila T.^ORCID,Munhoz Daniel B.,Cintra Riobaldo M.R.^ORCID,Breder Jessica Cunha,Barreto Joaquim,Nadruz Wilson^ORCID,Carvalho Luiz Sergio F.^ORCID,Quinaglia Thiago^ORCID,Arieta Carlos E.L.,Sposito Andrei C.^ORCID

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference25 articles.

1. Strategies to tackle the global burden of diabetic retinopathy: from epidemiology to artificial intelligence;Wong;Ophthalmologica,2020

2. Early detection of diabetic retinopathy;Safi;Surv Ophthalmol,2018

3. Neurodegeneration in type 2 diabetes: evidence from spectral-domain optical coherence tomography;Chhablani;Invest Ophthalmol Vis Sci,2015

4. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy;Virgili;Cochrane Database Syst Rev,2015

5. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus;Sohn;Proc Natl Acad Sci U S A,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis;Expert Review of Clinical Pharmacology;2024-09-11

2. Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database;Diabetologia;2024-04-08

3. Evaluation of the effect of sodium-glucose cotransporter-2 inhibitor treatment on choroidal vascular parameters in patients with type 2 diabetes mellitus;Photodiagnosis and Photodynamic Therapy;2023-12

4. The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern;Frontiers in Endocrinology;2023-11-09

5. Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists;Diabetes & Metabolism Journal;2023-05-31